Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat

by David S. Mathiesen, Asger Lund, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Jonatan I. Bagger, Jonatan I. Bagger
Published 2021-01-01

How glucagon-like peptide 1 receptor agonists work

by Christine Rode Andreasen, Andreas Andersen, Filip Krag Knop, Tina Vilsbøll
Published 2021-07-01

Hypoglycaemia and cardiac arrhythmias in diabetes

by Andreas Andersen, Peter G. Jørgensen, Filip K. Knop, Tina Vilsbøll
Published 2020-05-01

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

by Marta Seghieri, Marta Seghieri, Alexander S. Christensen, Andreas Andersen, Anna Solini, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll
Published 2018-11-01

The quality of dietary carbohydrate and fat is associated with better metabolic control in persons with type 1 and type 2 diabetes

by Sabine S. Jacobsen, Dorte Vistisen, Tina Vilsbøll, Jens M. Bruun, Bettina Ewers
Published 2020-11-01

No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course

by Kristian H. Mikkelsen, Tina Vilsbøll, Jens J. Holst, Bolette Hartmann, Filip K. Knop, Morten Frost
Published 2018-09-01

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.

by Andrea Mari, Jonatan I Bagger, Ele Ferrannini, Jens J Holst, Filip K Knop, Tina Vilsbøll
Published 2013-01-01

Model‐Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans

by Benjamin Guiastrennec, David P. Sonne, Martin Bergstrand, Tina Vilsbøll, Filip K. Knop, Mats O. Karlsson
Published 2018-09-01

Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes

by Regitse H. Christensen, Bernt Johan von Scholten, Christian S. Hansen, Magnus T. Jensen, Tina Vilsbøll, Peter Rossing, Peter G. Jørgensen
Published 2019-08-01

The Effects of Dual GLP-1/GIP Receptor Agonism on Glucagon Secretion—A Review

by David S. Mathiesen, Jonatan I. Bagger, Natasha C. Bergmann, Asger Lund, Mikkel B. Christensen, Tina Vilsbøll, Filip K. Knop
Published 2019-08-01

Is it Time to Transform Our Treatment Of Type 2 Diabetes

by Michael Nauck, Dídac Mauricio, Anthony Barnett, Tina Vilsbøll, Samy Hadjadj, Peter Rossing, Edoardo Mannucci, Harald Darius, Chantal Mathieu
Published 2013-10-01

Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.

by Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll
Published 2016-01-01

Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative review

by Birgitte B. Bennich, Michael E. Røder, Dorthe Overgaard, Ingrid Egerod, Lene Munch, Filip K. Knop, Tina Vilsbøll, Hanne Konradsen
Published 2017-07-01

A 25-Year-Old Woman with Type 2 Diabetes and Liver Disease

by Anders Ellekær Junker, Lise Lotte Gluud, Jens Pedersen, Jill Levin Langhoff, Jens Juul Holst, Filip Krag Knop, Tina Vilsbøll
Published 2014-12-01

Dialysis-Requiring Acute Kidney Injury in Denmark 2000-2012: Time Trends of Incidence and Prevalence of Risk Factors-A Nationwide Study.

by Nicholas Carlson, Kristine Hommel, Jonas Bjerring Olesen, Anne-Merete Soja, Tina Vilsbøll, Anne-Lise Kamper, Christian Torp-Pedersen, Gunnar Gislason
Published 2016-01-01

Trends in One-Year Outcomes of Dialysis-Requiring Acute Kidney Injury in Denmark 2005-2012: A Population-Based Nationwide Study.

by Nicholas Carlson, Kristine Hommel, Jonas Bjerring Olesen, Anne-Merete Soja, Tina Vilsbøll, Anne-Lise Kamper, Christian Torp-Pedersen, Gunnar Gislason
Published 2016-01-01

Inability of Some Commercial Assays to Measure Suppression of Glucagon Secretion

by Nicolai J. Wewer Albrechtsen, Simon Veedfald, Astrid Plamboeck, Carolyn F. Deacon, Bolette Hartmann, Filip K. Knop, Tina Vilsboll, Jens J. Holst
Published 2016-01-01

MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction

by Jesper Jensen, Morten Schou, Caroline Kistorp, Jens Faber, Tine W. Hansen, Magnus T. Jensen, Henrik U. Andersen, Peter Rossing, Tina Vilsbøll, Peter G. Jørgensen
Published 2020-10-01

Hepatic microbiome in healthy lean and obese humans

by Malte Palm Suppli, Jonatan Ising Bagger, Benjamin Lelouvier, Amandine Broha, Mia Demant, Merete Juhl Kønig, Charlotte Strandberg, Asger Lund, Tina Vilsbøll, Filip Krag Knop
Published 2021-08-01

Circulating Levels of the Soluble Receptor for AGE (sRAGE) during Escalating Oral Glucose Dosages and Corresponding Isoglycaemic i.v. Glucose Infusions in Individuals with and with...

by Amelia K. Fotheringham, Jonatan I. Bagger, Danielle J. Borg, Domenica A. McCarthy, Jens J. Holst, Tina Vilsbøll, Filip K. Knop, Josephine M. Forbes
Published 2020-09-01